D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$997M |
| 2 |
Meta Platforms (Facebook)
META
|
+$626M |
| 3 |
Microsoft
MSFT
|
+$482M |
| 4 |
T-Mobile US
TMUS
|
+$416M |
| 5 |
Uber
UBER
|
+$350M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$547M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$490M |
| 3 |
Johnson & Johnson
JNJ
|
+$444M |
| 4 |
Apple
AAPL
|
+$435M |
| 5 |
Accenture
ACN
|
+$378M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.68% |
| 2 | Consumer Discretionary | 8.8% |
| 3 | Healthcare | 8.52% |
| 4 | Financials | 6% |
| 5 | Industrials | 5.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Horizon Bancorp
HBNC
$1.05B
| $275K | ﹤0.01% |
26,451
+9,180
| +53% | +$91.1K |
|
|
NVO
3502
CALL
Novo Nordisk
NVO
$220B
| $275K | ﹤0.01% |
+3,400
| New | +$278K |
|
|
HLTH
3503
DELISTED
Cue Health Inc. Common Stock
HLTH
| $275K | ﹤0.01% |
744,739
+350,604
| +89% | +$299K |
|
|
GORV
3504
DELISTED
Lazydays
GORV
| $275K | ﹤0.01% |
792
+264
| +50% | +$90.6K |
|
|
FL
3505
DELISTED
Foot Locker
FL
| $274K | ﹤0.01% |
10,125
+1,125
| +13% | +$38.3K |
|
3506
Blackstone Mortgage Trust
BXMT
$2.8B
| $274K | ﹤0.01% |
13,187
-33,468
| -72% | -$615K |
|
3507
ATN International
ATNI
$364M
| $274K | ﹤0.01% |
7,490
-100
| -1% | -$3.84K |
|
3508
Organon & Co
OGN
$3.56B
| $274K | ﹤0.01% |
+13,150
| New | +$286K |
|
3509
CALL
Teva Pharmaceuticals
TEVA
$36.2B
| $273K | ﹤0.01% |
36,300
| – | – |
|
|
PNNT
3510
Pennant Park Investment Corp
PNNT
$219M
| $273K | ﹤0.01% |
46,365
-81,252
| -64% | -$439K |
|
3511
Atossa Therapeutics
ATOS
$23.5M
| $273K | ﹤0.01% |
14,435
-40,456
| -74% | -$491K |
|
|
HLLY.WS
3512
DELISTED
Holley Inc Warrants
HLLY.WS
| $272K | ﹤0.01% |
542,429
+201,667
| +59% | +$72.5K |
|
3513
NetEase
NTES
$79.2B
| $271K | ﹤0.01% |
+2,800
| New | +$253K |
|
3514
Northeast Bank
NBN
$1.14B
| $268K | ﹤0.01% |
6,434
-11,116
| -63% | -$422K |
|
|
AMRN
3515
Amarin Corp
AMRN
$290M
| $267K | ﹤0.01% |
11,213
-9,321
| -45% | -$239K |
|
3516
Oil States International
OIS
$512M
| $266K | ﹤0.01% |
35,664
-9,894
| -22% | -$72.2K |
|
3517
Utah Medical Products
UTMD
$220M
| $264K | ﹤0.01% |
2,830
+442
| +19% | +$41.6K |
|
3518
Avista
AVA
$3.43B
| $263K | ﹤0.01% |
6,700
-77,596
| -92% | -$3.29M |
|
3519
Lumentum
LITE
$55.4B
| $263K | ﹤0.01% |
4,636
-79,474
| -94% | -$3.97M |
|
|
SLGC
3520
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $262K | ﹤0.01% |
113,248
-93,859
| -45% | -$265K |
|
3521
Drilling Tools International
DTI
$78.7M
| $262K | ﹤0.01% |
60,000
-830,957
| -93% | -$7.14M |
|
3522
Asbury Automotive
ABG
$4.22B
| $261K | ﹤0.01% |
1,087
-23,946
| -96% | -$5.03M |
|
3523
CALL
Fiverr
FVRR
$398M
| $260K | ﹤0.01% |
10,000
| – | – |
|
3524
QCR Holdings
QCRH
$1.65B
| $260K | ﹤0.01% |
6,339
-1,378
| -18% | -$56.4K |
|
3525
Movado Group
MOV
$835M
| $258K | ﹤0.01% |
+9,623
| New | +$252K |
|
Similar funds
D.E. Shaw & Co's Q2 2023 Portfolio in Review
As of Q2 2023, D.E. Shaw & Co held 4,841 positions worth $97.9B, up 4.8% from $93.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $4.46B in Q2 2023, closing 639 positions and reducing 1,586 holdings. Its most notable exit was Shaw Communications Inc., an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Oracle worth $217M.
- D.E. Shaw & Co's largest Q2 2023 buy was Oracle: 1,825,762 shares worth $217M.
- D.E. Shaw & Co added most to NVIDIA in Q2 2023, an estimated $997M increase.
- D.E. Shaw & Co's biggest Q2 2023 reduction was Visa, cutting an estimated $547M.
- D.E. Shaw & Co fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $152M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $97.9B portfolio in Q2 2023.
- D.E. Shaw & Co opened 467 new positions and closed 639 in Q2 2023.
- D.E. Shaw & Co's portfolio value rose 4.8% quarter-over-quarter to $97.9B.
Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.